药物耐药性的翻译后修改
Chenggui Miao1, Yurong Huang2, Cheng Zhang3
1School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 999077, Hong Kong; Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, Anhui University of Chinese Medicine, Hefei 230012, China; Department of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei 230012, China.
蛋白质后翻译修饰 (PTMs) 是癌症,细菌和病毒感染中耐药性的关键驱动因素. 了解这些修改为克服治疗挑战提供了新的治疗目标.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对抗癌症,抗微生物和抗病毒疗法的耐药性显著阻碍了治疗疗效和患者的治疗结果.
- 蛋白质转化后修饰 (PTMs),包括糖化,无化和化,越来越多地被认为是药物耐药性的关键调节者.
- 这些修改涉及对蛋白质的各种分子的共价添加,影响其在细胞信号通路中的功能和稳定性.
研究的目的:
- 审查PTM在药物耐药性发展中的多方面的作用.
- 突出PTM作为诱导剂和潜在的目标来逆转耐药性.
- 为了解决药物耐药性的新药标和治疗策略提供见解.
主要方法:
- 文献综述和对PTM和耐药性现有研究的综合.
- 在抗瘤,抗微生物和抗病毒药物耐药性的背景下分析PTM机制.
- 特定的PTM的识别,涉及到阻力路径.
主要成果:
- PTM是抗瘤药物耐药性的组成部分,既是治疗干预的驱动因素,也是治疗干预的潜在目标.
- 细菌使用各种PTM来调解对抗菌药物的耐药性.
- 由PTMs诱导的复杂蛋白相互作用网络有助于抗病毒药物耐药性.
结论:
- 在多种药物耐药性机制中,PTMs起着至关重要的作用,影响癌症,细菌和病毒疾病.
- 针对PTM是一个有前途的途径,可以开发新的策略来打击耐药性.
- 对PTM的进一步研究可以指导开发改进的治疗计划和药物标.
更多相关视频
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
相关概念视频
Treatment Resistant Cancers
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Drug Biotransformation: Overview
Development of Antibiotic Resistance
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
